Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Apr. 30, 2025	Sumitomo Pharma Announces Organizational Realignment and Personnel Changes	Corporate
Apr. 28, 2025	Sumitomo Pharma Announces Revisions to Its Financial Forecasts and Recording of Gains from Transfer of Equity Interests	Finances
Apr. 28, 2025	Notice Concerning Reversal of Allowance for Doubtful Accounts of Subsidiaries and Affiliates in Company’s Non-consolidated Financial Statements (Japanese GAAP)	Finances
Apr. 17, 2025	Sumitomo Pharma Announces Changes in the Positions Assumed by Executive Officers and Other Key Position	Corporate
Apr. 04, 2025	Sumitomo Pharma Announces Reduction in Executive Remuneration	Finances
Apr. 01, 2025	Notice Regarding a Company Split (Simplified Absorption-Type Company Split) of the Asian Business and the Execution of a Share Transfer Agreement and a Shareholders’ Agreement with Marubeni Global Pharma Corporation	Corporate

May 13, 2025	FY2024 financial results announcement/Reboot 2027 - Reboot for a Strong Sumitomo Pharma -, Analysts, Investors, and the Press conference of financial results FY2024 (planned, 13:00 p.m.)